Strides Pharma Science Limited has informed the Exchange regarding a press release dated December 22, 2022, titled “Receipt of AUD 94 million on account of deferred consideration on the sale of……
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
